A large comparative effectiveness study presented at the fourth annual Genitourinary Cancers Symposium, being held February 2-4, 2012, at the San Francisco Marriott Marquis in San Francisco, Ca, USA, shows that men with localized prostate cancer who are treated with Intensity Modulated Radiation Therapy or IMRT are less likely to experience cancer recurrences or significant side effects from treatment than those who receive conventional conformal radiation therapy…
Contributor
More from this contributor
- Blinatumomab Achieved High Rate ...
- Fidaxomicin Offers Faster Diarrh...
- Rilotumumab Moves into Phase III...
- Study Shows ImmunoSEQ Assay Sign...
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.